Incyte (INCY) Capital Leases (2018 - 2026)
Incyte posted quarterly Capital Leases of $29.4 million for Q1 2026, down 9.89% year-on-year from $32.6 million in Q1 2025, and down 2.6% on a QoQ basis from $30.2 million in Q4 2025.
Incyte (INCY) has 9 years of Capital Leases data on file, last reported at $29.4 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Leases fell 9.89% year-over-year to $29.4 million; the trailing twelve-month figure through Mar 2026 stood at $29.4 million (down 9.89% YoY), and the FY2025 full-year result was $30.2 million, down 9.97% from the prior year.
- Capital Leases for Q1 2026 stood at $29.4 million, down from $30.2 million in the prior quarter.
- Across five years, Capital Leases topped out at $33.5 million in Q4 2024 and bottomed at $28.2 million in Q3 2024.
- The 5-year median for Capital Leases is $30.1 million (2022), against an average of $30.3 million.
- The widest annual swing landed in 2024, when Capital Leases climbed 15.02%; it then dropped 9.97% in 2025.
- A 5-year view of Capital Leases shows it stood at $30.1 million in 2022, then dropped by 3.06% to $29.2 million in 2023, then increased by 15.02% to $33.5 million in 2024, then dropped by 9.97% to $30.2 million in 2025, then declined by 2.6% to $29.4 million in 2026.
- The last three Capital Leases figures came in at $29.4 million (Q1 2026), $30.2 million (Q4 2025), and $30.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.41 Mn |
| Dec 31, 2025 | 30.20 Mn |
| Sep 30, 2025 | 30.88 Mn |
| Jun 30, 2025 | 31.76 Mn |
| Mar 31, 2025 | 32.64 Mn |
| Dec 31, 2024 | 33.54 Mn |
| Sep 30, 2024 | 28.22 Mn |
| Jun 30, 2024 | 28.75 Mn |
| Mar 31, 2024 | 28.93 Mn |
| Dec 31, 2023 | 29.16 Mn |
| Sep 30, 2023 | 28.86 Mn |
| Jun 30, 2023 | 29.49 Mn |
| Mar 31, 2023 | 29.70 Mn |
| Dec 31, 2022 | 30.08 Mn |
| Sep 30, 2022 | 30.48 Mn |
| Jun 30, 2022 | 31.16 Mn |
| Mar 31, 2022 | 31.39 Mn |
| Dec 31, 2021 | 31.63 Mn |
| Sep 30, 2021 | 31.38 Mn |
| Jun 30, 2021 | 31.84 Mn |
| Mar 31, 2021 | 32.15 Mn |
| Dec 31, 2020 | 32.57 Mn |
| Sep 30, 2020 | 32.85 Mn |
| Jun 30, 2020 | 31.92 Mn |
| Mar 31, 2020 | 31.96 Mn |
| Dec 31, 2019 | 31.92 Mn |
| Jun 30, 2019 | 31.64 Mn |
| Dec 31, 2018 | 18.70 Mn |